Planned Rule 144 sale of LRCX common stock

A holder of common stock of LRCX has filed a notice of proposed sales under Rule 144.

Rhea-AI Filing Summary

A holder of common stock of LRCX has filed a notice of proposed sales under Rule 144. The filing lists up to 18,282 shares, with an indicated aggregate market value of $6,124,470.00, to be sold through Fidelity Brokerage Services LLC on or after July 13, 2026 on the NASDAQ market.

The shares relate to prior restricted stock vesting events received from the issuer as compensation on several dates between 2014 and 2025.

Filing Explained

The July 13 filing lists 18,282 common shares for sale, but documents neither a completed sale nor a new Lam Research issuance.

The July 13, 2026 Form 144 lists 18,282 Lam Research common shares in its “Securities To Be Sold” section, but the supplied filing does not state that the sale was completed.

Because the filing identifies the securities as shares to be sold, rather than a new company issuance, it does not document added shares or proceeds for Lam Research.

The listed shares are attributed to restricted-stock vesting and compensation: 6,012 shares dated January 31, 2014, 5,630 dated October 31, 2023, 3,690 dated October 31, 2024, and 2,950 dated October 31, 2025.

The “Securities Sold During The Past 3 Months” section contains no reported transaction in the supplied text, so the filing provides no completed-sale amount to add to the 18,282 shares listed for sale.

Key Figures

Shares Proposed for Sale: 18,282 shares Aggregate Market Value: $6,124,470.00 Proposed Sale Date: 07/13/2026 +4 more

7 metrics

Shares Proposed for Sale 18,282 shares Common stock covered by Rule 144 notice

Aggregate Market Value $6,124,470.00 Value of 18,282 common shares proposed for sale

Proposed Sale Date 07/13/2026 Date from which NASDAQ sales may occur

Restricted Stock Vesting 2014 6,012 shares Restricted stock vesting on 01/31/2014 as compensation

Restricted Stock Vesting 2023 5,630 shares Restricted stock vesting on 10/31/2023 as compensation

Restricted Stock Vesting 2024 3,690 shares Restricted stock vesting on 10/31/2024 as compensation

Restricted Stock Vesting 2025 2,950 shares Restricted stock vesting on 10/31/2025 as compensation

Key Terms

Rule 144, restricted stock vesting, aggregate market value, compensation

4 terms

Rule 144 regulatory

"A holder of common stock of LRCX has filed a notice of proposed sales under Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock vesting financial

"The shares relate to prior restricted stock vesting events received from the issuer as compensation."

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

aggregate market value financial

"The filing lists up to 18,282 shares, with an indicated aggregate market value of $6,124,470.00."

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

compensation financial

"The shares relate to prior restricted stock vesting events received from the issuer as compensation."

FAQ

What does the Form 144 filing for LRCX disclose?

The filing discloses a proposed sale under Rule 144 of 18,282 shares of LRCX common stock, with an indicated aggregate market value of $6,124,470.00, to be sold on NASDAQ.

How many LRCX shares are proposed to be sold and through whom?

The notice covers up to 18,282 shares of LRCX common stock, with Fidelity Brokerage Services LLC listed as the broker handling the planned NASDAQ sales.

When are the LRCX shares in the Form 144 expected to be sold?

The proposed sale date is listed as 07/13/2026. This is the date from which the holder may begin selling the registered shares under Rule 144 on NASDAQ.

What is the indicated market value of the LRCX shares in this Form 144?

The filing shows an aggregate market value of $6,124,470.00 for the 18,282 LRCX shares covered by the proposed Rule 144 sale on NASDAQ.

How were the LRCX shares in this Form 144 originally acquired?

The shares are tied to several restricted stock vesting events from the issuer, granted as compensation on dates including 01/31/2014, 10/31/2023, 10/31/2024, and 10/31/2025.

What compensation-related vesting details are included for LRCX in this Form 144?

The notice lists restricted stock vesting of 6,012 shares on 01/31/2014, 5,630 on 10/31/2023, 3,690 on 10/31/2024, and 2,950 on 10/31/2025, all as compensation from the issuer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/13/2026 - 10:07 AM Accepted by SEC EDGAR 07/13/2026 - 10:06 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001316065
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	LAM RESEARCH CORP
SEC File Number	000-12933
Address of Issuer	4650 CUSHING BLVD FREMONT CALIFORNIA 94538
Phone	5106590200
Name of Person for Whose Account the Securities are To Be Sold	TALWALKAR ABHIJIT Y
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	18282	6124470.00	1250571000	07/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/31/2014	Restricted Stock Vesting	Issuer			6012	01/31/2014	Compensation
Common	10/31/2023	Restricted Stock Vesting	Issuer			5630	10/31/2023	Compensation
Common	10/31/2024	Restricted Stock Vesting	Issuer			3690	10/31/2024	Compensation
Common	10/31/2025	Restricted Stock Vesting	Issuer			2950	10/31/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	07/13/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gary Redman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Abhi Talwalkar
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)